Thailand Neurovascular Devices/Interventional Neurology Market Forecast 2023-2030
KEY FINDINGS
The Thailand neurovascular devices/interventional neurology market is projected to rise with a CAGR of 6.23% during the forecast years. The country’s market growth is fuelled by the increasing geriatric population as well as the surging rates of Alzheimer’s disease. The base year considered for the studied market is 2022, and the forecasting period is between 2023 to 2030.
MARKET INSIGHTS
Stroke poses a major health burden in Thailand, ranking as the leading cause of death and long-term disability in both men and women. Its prevalence is estimated to be 1.88% among adults aged 45 and older, with a higher incidence in men and an average onset age of 65 years. These compelling factors are poised to drive further expansion in the neurovascular disorder treatment market in Thailand. As the demand for specialized care and advanced treatments increases, the country’s healthcare sector will play a crucial role in addressing the challenges posed by these neurological conditions.
Alzheimer’s disease is becoming increasingly prevalent in Thailand, impacting approximately 3-5% of the population, with dementia-related deaths accounting for 5.13% of total mortality. Future projections indicate that by 2030, the number of Alzheimer’s patients in Thailand will soar to 1,117,000. This alarming trend is fueling a substantial surge in the demand for effective treatments to address this neurodegenerative disorder. Thus, such factors are set to bolster the Thailand neurovascular devices/interventional neurology market growth over the forecast period.
COMPETITIVE INSIGHTS
Leading enterprises operating in the market include Johnson & Johnson (Cerenovus), Balt, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Country Snapshot
- 2.3. Country Analysis
- 2.4. Scope Of Study
- 2.5. Crisis Scenario Analysis
- 2.5.1. Impact Of Covid-19 On Neurovascular Devices/Interventional Neurology Market
- 2.6. Major Market Findings
- 2.6.1. Government Initiatives To Create Awareness About Neurovascular Diseases
- 2.6.2. Early Detection Of Arteriovenous Malformation (Avm)
- 2.6.3. Thrombectomy Improves Patient Outcomes And Reduces Disability Rate
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Significant Rise In Incidence Of Neurovascular Conditions
- 3.1.2. Preference For Minimally Invasive Procedures
- 3.1.3. Geriatric Population’s Vulnerability To Neurovascular Diseases
- 3.1.4. Underlying Diseases Are A Risk Factor For Neurovascular Diseases
- 3.2. Key Restraints
- 3.2.1. Exorbitant Costs Of Neurovascular Devices
- 3.2.2. Lack Of Trained Neurosurgeons
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Buyers Power
- 4.2.2. Suppliers Power
- 4.2.3. Substitution
- 4.2.4. New Entrants
- 4.2.5. Industry Rivalry
- 4.3. Growth Prospect Mapping
- 4.3.1. Growth Prospect Mapping For Thailand
- 4.4. Market Concentration Analysis
- 4.5. Value Chain Analysis
- 5. Market By Product
- 5.1. Embolization Devices
- 5.1.1. Embolic Coils
- 5.1.1.1. Coated Detachable Coils
- 5.1.1.2. Bare Detachable Coils
- 5.1.2. Coil Assist Stent
- 5.1.3. Clippings
- 5.1.4. Coil Assist Balloon
- 5.2. Accessory Devices
- 5.2.1. Microcatheters
- 5.2.2. Micro Guidewires
- 5.3. Revascularization Devices
- 5.3.1. Carotid Artery Stents
- 5.3.2. Flow Diversion Stents
- 5.4. Thrombectomy Devices
- 5.4.1. Clot Retrieval Devices
- 5.4.2. Suction And Aspiration Devices
- 5.4.3. Snares
- 5.5. Embolic Protection Devices
- 5.5.1. Balloon Occlusion Devices
- 5.5.2. Distal Filter Devices
- 6. Market By Application
- 6.1. Aneurysm
- 6.2. Ischemic Stroke
- 6.3. Stenosis
- 6.4. Arteriovenous Malformation (Avm)
- 6.5. Other Applications
- 7. Competitive Landscape
- 7.1. Key Strategic Developments
- 7.1.1. Mergers & Acquisitions
- 7.1.2. Product Launches & Developments
- 7.1.3. Partnerships & Agreements
- 7.1.4. Business Expansions & Divestitures
- 7.2. Company Profiles
- 7.2.1. Acandis Gmbh
- 7.2.1.1. Company Overview
- 7.2.1.2. Product List
- 7.2.2. Balt
- 7.2.2.1. Company Overview
- 7.2.2.2. Product List
- 7.2.3. Johnson & Johnson (Cerenovus)
- 7.2.3.1. Company Overview
- 7.2.3.2. Product List
- 7.2.3.3. Strengths & Challenges
- 7.2.4. Medtronic Inc
- 7.2.4.1. Company Overview
- 7.2.4.2. Product List
- 7.2.4.3. Strengths & Challenges
- 7.2.5. Phenox Inc
- 7.2.5.1. Company Overview
- 7.2.5.2. Product List
- 7.2.5.3. Strengths & Challenges
- 7.2.6. Stryker Corporation
- 7.2.6.1. Company Overview
- 7.2.6.2. Product List
- 7.2.6.3. Strengths & Challenges
- 7.2.7. Terumo Corporation
- 7.2.7.1. Company Overview
- 7.2.7.2. Product List
- 7.2.7.3. Strengths & Challenges
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook